Ed Silverman

Lilly gave hospitals participating in a federal drug discount program five days to submit claims data or it will stop the price breaks

Taking weight loss drugs for at least three years could prevent thousands of knee replacements a year, a new study found

Eli Lilly is halving its originally planned investment in the production of weight loss syringes in Germany in response to a cost-cutting law

On a cold, gray afternoon in February, a steady flow of cars filled a gravel parking lot and adjacent stretches of patchy grass at Bernie's Hillside Lounge, a cozy roadside tavern located on an out-of-the-way back road in Chester.

Amy Johnston is distraught and readily admits that she is “grasping at straws.” Diagnosed last year with pancreatic cancer, she has had chemotherapy and

The Supreme Court unanimously ruled that Hikma Pharmaceuticals did not infringe patents held by Amarin in a decision that makes generic drugmakers less vulnerable to lawsuits over so-called skinny labels.

Drugmakers and patient groups asked the FDA to pause former commissioner Marty Markary's National Priority Voucher drug review program

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

Lilly disclosed new data that provide more details on the safety and tolerability of its next-generation obesity drug retatrutide

GSK agreed to buy Nuvalent, a cancer drug developer, in a deal worth $10.6 billion, as the company continues its expansion in oncology